Beshom Holdings (7668) Fair Value & Analysis
Healthcare · MY · Market cap 190M MYR
Fair value as of: Jun 24, 2026
Analysis
Beshom Holdings (7668) currently trades at 0.5550 MYR, while our model-based Fair Value estimate is 0.6300 MYR — implying the stock looks roughly 13.5% undervalued today. We read business quality at 90/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Beshom Holdings Berhad, an investment holding company, engages in the wholesale and retail of herbal medicines and healthcare products in Malaysia. The company provides wholesaling and trading in patented medicines, medicated tonic, cooking wine, healthcare products, wellness, herbs, and tea. It also offers multi-level direct marketing of nutritional food and beverage, wellness supplements, skincare, beauty and cosmetic, personal care and household products. In addition, it provides operating traditional complementary medicines (TCM) retail chain stores and physician consultation services. Further, it engages in manufacturing of TCM supplements; credit and leasing; insurance agency; and investment holding and property holding. The company operates retail chain stores and franchises; and multi-level-marketing branches, stockists, and sales points. The company was founded in 1975 and is headquartered in Petaling Jaya, Malaysia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Beshom Holdings (7668) undervalued?
What is the fair value of 7668?
What is the quality score of 7668?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.